Keep in mind we have two more sites that SPORT has just been installed, or will be shortly (within Q4). Surgeon feedback, reviews, are scheduled this quarter before year end. After the VERY positive, glowing remarks from 3 renowned surgeons at the first site (Nicholson), what are the chances the 2nd and 3rd site surgeons will have a different/critical take?? I'm guessing slim to none. I can't see Patel and company getting it that wrong.
With that said, it's nice to have some forthcoming (almost certainly) positive SPORT reviews up are sleeve. Hence, my view we end up at .50+ by year end. Sure dilutive financing could temporarily derail this, but I believe they are holding out on this until after the 2nd and 3rd site feedback/reviews. They want as much pop as they can get before going back to the well...JMHO
GLTA
News 
Market Data 
Discover 
AI
